Springer Nature OAopen access
Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in Spain
Medicine & Public Health, Internal Medicine, Oncology, Cardiology, Rheumatology, Endocrinology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 479680
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.